We are live on ! Find out more
BMO

Beck Mack & Oliver Portfolio holdings

AUM $4.85B
1-Year Est. Return 9.66%
This Fund
S&P 500
This Quarter Est. Return
-15.9%
1 Year Est. Return
+9.66%
3 Year Est. Return
+69.39%
5 Year Est. Return
+96.17%
10 Year Est. Return
+350.87%
AUM
$2.49B
AUM Growth
-$656M
Cap. Flow
-$84.6M
Cap. Flow %
-3.39%
Top 10 Hldgs %
39.14%
Holding
242
New
12
Increased
27
Reduced
100
Closed
17

Top Buys

Rank Stock Value
1
SHW icon
Sherwin-Williams
SHW
+$27M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$10.1M
3
WAT icon
Waters Corp
WAT
+$6.41M
4
EPD icon
Enterprise Products Partners
EPD
+$3.16M
5
LH icon
Labcorp
LH
+$3.14M

Top Sells

Rank Stock Value
1
MDR
McDermott International
MDR
+$30.5M
2
SLB icon
SLB Ltd
SLB
+$24.4M
3
LBTYA icon
Liberty Global Class A
LBTYA
+$12.9M
4
QCOM icon
Qualcomm
QCOM
+$11.1M
5
MSFT icon
Microsoft
MSFT
+$7.5M

Sector Composition

Rank Sector Weight
1 Financials 30.05%
2 Healthcare 18.3%
3 Technology 12.11%
4 Communication Services 10.64%
5 Industrials 7.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IBM icon
101
IBM
IBM
$213B
$1.28M 0.05%
11,814
-9,409
-44% -$1.13M
GLD icon
102
SPDR Gold Trust
GLD
$131B
$1.23M 0.05%
10,173
+92
+0.9% +$10.7K
VTI icon
103
Vanguard Total Stock Market ETF
VTI
$646B
$1.2M 0.05%
9,415
-485
-5% -$67K
BMY icon
104
Bristol-Myers Squibb
BMY
$129B
$1.19M 0.05%
22,872
-300
-1% -$16.1K
AMGN icon
105
Amgen
AMGN
$209B
$1.05M 0.04%
5,400
-800
-13% -$156K
WLY icon
106
John Wiley & Sons Class A
WLY
$2.83B
$1.02M 0.04%
21,636
-466
-2% -$25.1K
CBSH icon
107
Commerce Bancshares
CBSH
$8.68B
$985K 0.04%
24,599
-4
-0% -$171
HON icon
108
Honeywell
HON
$76.4B
$964K 0.04%
7,745
-1,124
-13% -$153K
CNI icon
109
Canadian National Railway
CNI
$78.5B
$955K 0.04%
12,883
– –
IEX icon
110
IDEX
IEX
$17B
$951K 0.04%
7,536
– –
V icon
111
Visa
V
$701B
$951K 0.04%
7,209
-1,000
-12% -$138K
BRC icon
112
Brady Corp
BRC
$4.46B
$939K 0.04%
21,600
– –
CMCSA icon
113
Comcast
CMCSA
$87.3B
$930K 0.04%
27,303
– –
DE icon
114
Deere & Co
DE
$165B
$925K 0.04%
6,200
– –
RNR icon
115
RenaissanceRe
RNR
$13.8B
$921K 0.04%
6,885
-150
-2% -$19.6K
VOO icon
116
Vanguard S&P 500 ETF
VOO
$956B
$915K 0.04%
3,983
– –
VWO icon
117
Vanguard FTSE Emerging Markets ETF
VWO
$117B
$898K 0.04%
+23,576
New +$913K
PEG icon
118
Public Service Enterprise Group
PEG
$38.7B
$854K 0.03%
16,400
– –
LSXMK
119
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$853K 0.03%
30,271
– –
CSCO icon
120
Cisco
CSCO
$443B
$845K 0.03%
19,500
– –
DVN icon
121
Devon Energy
DVN
$51.3B
$845K 0.03%
37,500
-52,602
-58% -$1.62M
BSX icon
122
Boston Scientific
BSX
$68.4B
$816K 0.03%
23,100
-400
-2% -$14.5K
MCD icon
123
McDonald's
MCD
$193B
$781K 0.03%
4,400
+5
+0.1% +$887
CVS icon
124
CVS Health
CVS
$135B
$778K 0.03%
11,877
+251
+2% +$18.7K
EW icon
125
Edwards Lifesciences
EW
$49.4B
$772K 0.03%
15,120
– –
3 4
5
6 7

Similar funds

SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
MCCA
Mill Creek Capital Advisors Conshohocken, Pennsylvania $4.87B AUM 17.69% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
TPCW
TD Private Client Wealth New York $4.82B AUM 15.21% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
JSTA
Japan Science & Technology Agency Tokyo, Japan $4.81B AUM 4.62% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
KCM
Kensico Capital Management Greenwich, Connecticut $4.9B AUM 41.26% 1-Year Est. Return

Beck Mack & Oliver's Q4 2018 Portfolio in Review

As of Q4 2018, Beck Mack & Oliver held 242 positions worth $2.49B, down 21% from $3.15B the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Beck Mack & Oliver withdrew a net $84.6M in Q4 2018, closing 17 positions and reducing 100 holdings. Its most notable exit was McDermott International, an estimated $30.5M position sold in full.

By sector, the portfolio is most concentrated in Financials at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Beck Mack & Oliver opened a new position in Sherwin-Williams worth $26.3M.

  • Beck Mack & Oliver's largest Q4 2018 buy was Sherwin-Williams: 200,220 shares worth $26.3M.
  • Beck Mack & Oliver added most to Teva Pharmaceuticals in Q4 2018, an estimated $10.1M increase.
  • Beck Mack & Oliver's biggest Q4 2018 reduction was SLB Ltd, cutting an estimated $24.4M.
  • Beck Mack & Oliver fully exited McDermott International in Q4 2018, selling an estimated $30.5M.
  • Beck Mack & Oliver's ten largest holdings make up 39% of its $2.49B portfolio in Q4 2018.
  • Beck Mack & Oliver opened 12 new positions and closed 17 in Q4 2018.
  • Beck Mack & Oliver's portfolio value fell 21% quarter-over-quarter to $2.49B.

Based on Beck Mack & Oliver's 13F filing for Q4 2018, filed 4 Feb 2019.